ALMS — ALUMIS INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1847367 ·
Last close
$28.25
Market Cap
$3.49B
52W High
$31.35
52W Low
$18.36
ADV30
1,541,343
Next earnings
2026-08-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,741,000 | — | -98,409,000 | -93,053,000 | 671,588,000 | 63,885,000 | 104,567,000 |
| Dec 2025 | 1,929,000 | — | -96,445,000 | -92,931,000 | 411,940,000 | 89,670,000 | 110,643,000 |
| Sep 2025 | 2,066,000 | — | -115,292,000 | -110,752,000 | 488,014,000 | 65,257,000 | 103,241,000 |
| Jun 2025 | 2,666,000 | — | -140,539,000 | 59,321,000 | 610,925,000 | 151,753,000 | 125,598,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-376,250,000
Investing CF
$-37,237,000
Financing CF
$349,055,000
CapEx
$-1,183,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.05
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-994,929,000
Inventory
—
Receivables
$2,730,000
ST Investments
$459,058,000
EBIT TTM
$-450,685,000
Pretax Income TTM
$-245,976,000
Interest Exp TTM
—
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$8,402,000
EBITDA
$-435,260,992
Free Cash Flow
$-206,754,624
Enterprise Value
$3,114,369,536
Total Cash
$522,943,008
Total Debt
$35,664,000
Shares Out
123,432,072
Trailing EPS
$-1.78
Book Value
$4.46
ROE
-64.6%
ROA
-58.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 24,050,000 | -453,804,000 | -243,325,000 | 411,940,000 | 110,643,000 | — | -369,523,000 |
| Dec 2024 | 0 | -300,754,000 | -294,233,000 | 340,992,000 | 80,888,000 | — | -255,078,000 |
| Dec 2023 | 0 | -158,174,000 | -154,993,000 | 89,612,000 | 428,872,000 | — | -129,975,000 |
| Dec 2022 | 0 | -113,850,000 | -111,930,000 | 108,168,000 | 303,410,000 | — | -107,722,000 |
TTM Snapshot
Revenues TTM
$2,066,000
NetIncome TTM
$-136,494,000
OpCashFlow TTM
$0
Assets (Latest)
$340,992,000
Forward EPS
$-2.95
Max Pain — expiry 2026-09-18
max pain strike: $29.00 · spot: $28.25 · call oi: 2,821 · put oi: 4,228Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International, plc | $3.44B | $74.34 | — |
| RCUS | Arcus Biosciences, Inc. | $3.55B | $28.19 | — |
| IDYA | IDEAYA Biosciences, Inc. | $3.42B | $35.50 | — |
| OGN | Organon & Co. | $3.56B | $13.55 | — |
| GPCR | Structure Therapeutics Inc. | $3.41B | $48.04 | — |
News headlines (Yahoo Finance, 1h cache)
Stifel and Guggenheim Stay Bullish on Alumis (ALMS)
2026-07-01 21:23 · Yahoo
Analyst Sentiment On Alumis (ALMS) Remains Strong Following Q1 Results And Envudeucitinib Pipeline Advancements
2026-05-29 10:31 · Yahoo
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter
2026-05-24 14:33 · Yahoo
Is Alumis (ALMS) Trading Short-Term Revenue for a Leaner, More Focused Business Model?
2026-05-20 04:34 · Yahoo
Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares
2026-05-19 17:37 · Yahoo
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors
2026-05-19 17:26 · Yahoo
Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish
2026-05-18 17:33 · Yahoo
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
2026-05-17 18:33 · Yahoo
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back
2026-05-15 22:56 · Yahoo
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Amid Oil Surge, Higher Yields, Geopolitical Uncertainty
2026-05-15 13:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.